Status | Study |
Recruiting |
Study Name: Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors Condition: Medulloblastoma Astrocytoma, Grade III Glioblastoma Date: 2015-12-27 Interventions: Drug: Mebendazole chewable mebendazole tablets that can also be crushed and mixed with food or drink to |
Recruiting |
Study Name: A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment Condition: Anaplastic Oligoastrocytoma Anaplastic Astrocytoma Date: 2015-12-10 Interventions: Drug: β-elemene β-elemene 600mg/d,ivdrip,d1-14,every 28 days for 1 cycle, totally 6 cycles |
Terminated |
Study Name: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Condition: Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Astrocytoma Date: 2015-09-13 Interventions: Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging |
Not yet recruiting |
Study Name: Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma Condition: High Grade Malignant Neoplasm Glioblastoma Multiforme Date: 2015-09-01 Interventions: Other: flourescein Other: intraoperative M |
Recruiting |
Study Name: A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma Condition: Glioblastoma Anaplastic Astrocytoma Date: 2015-07-02 Interventions: Drug: Fingolimod Oral fingolimod will be given 1 week prior to the initiation of concurrent radiation an |
Recruiting |
Study Name: HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors Condition: Supratentorial Neoplasms, Malignant Date: 2015-05-20 Interventions: Biological: G207 Single dose of HSV-1 (G207) infused through catheters into region(s) of tumor defined b |
Active, not recruiting |
Study Name: P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA Condition: Glioblastoma Multiforme Anaplastic Astrocytoma Date: 2015-04-03 Interventions: Biological: Toca 511 Toca 511 |
Withdrawn |
Study Name: Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme (Phase II) Condition: Malignant Gliomas Date: 2015-02-16 Interventions: Drug: Irinotecan 200 mg/m^2 by |
Recruiting |
Study Name: Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors Condition: Glioma Pilocytic Astrocytoma Anaplas Date: 2015-02-13 Interventions: Device: MRI-guided laser ablation |
Recruiting |
Study Name: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Condition: Childhood Choroid Plexus Tumor Childhood Ependymoblastoma Date: 2014-09-30 Interventions: Drug: palbociclib isethionate |